×
We are eager to improve this site, feel free to give us some Feedback
GenPORT is funded by the European Union FP7-SCIENCE-IN-SOCIETY-2012-1 programme. Login Register
Digital Document (pdf, doc, ppt, txt, etc.)
About (English version):
The outbreak of the new coronavirus (COVID-19) was first reported in Wuhan, China on December 31, 2019. Since then a global pandemic has been declared, with countries across the globe mobilizing to respond to the health crisis and manage the significant socio-economic impacts.
Various organizations, institutions and platforms have thus developed toolkits, tools and guidelines on how to integrate gender and diversity as research content.
21 of such tools, among others IGAR, SAGER, GERD and PLOTINA, are listed and analyzed in this report concerning their content, focus, phrasing and potential usability for the addressed user groups.
These users might lack a profound knowledge on gender topics and the related terminology.
The results of this analysis provide insights concerning the design, content, and usability of such guiding materials thereby supporting the evaluation of the suitability for a certain field of application.
This is a critical time for medicine. As we observe the exponential rise in the number of individuals in the United States (US) who are infected with COVID-19, we try to prepare. Those in the front lines are trying to protect themselves and their patients with the daily ration of personal protective equipment and ventilation assistive equipment. Many individuals are racing against time to develop the needed novel treatments and vaccines. Public health officials work with what little information is known in order to make effective recommendations for prevention. However, at this pivotal time in history where every detail obtained by US health officials could be lifesaving, we are leaving out vital information.
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) emerged in Wuhan, China in late 2019 and spread globally resulting in the COVID-19 pandemic.1 During the two previous coronavirus epidemics, Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS), male sex was associated with worse clinical outcomes.2 Though there is limited sex-disaggregated COVID-19 incidence and outcome data, reports from epidemics in Italy and China indicate that men may also be more affected.1,3 It is unclear whether these findings may be skewed because of unreported sex-based differences in SARS-CoV-2 testing and the age distributions of study populations
